Evaluating Ultrasound as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis - Top-Institutions - MDSpire

Evaluating Ultrasound as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis

By
Qing Feng Shi
Peng Fei Hu
Yong Hong Liu
January 13, 2026
0 min

Bmc Cancer

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Breast Oncology
- Diagnostic Radiology
- Medical Oncology
#2

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Breast Surgery
- Radiology
- Medical Oncology
#3

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Medical Oncology
- Breast Cancer Research
- Radiology
#4

Johns Hopkins Medicine

Baltimore, MD
Key Differentiators
- Breast Oncology
- Radiology
- Surgical Oncology
#5

University of California, San Francisco (UCSF) Medical Center

San Francisco, CA
Key Differentiators
- Breast Imaging
- Medical Oncology
- Surgical Oncology

Original Source(s)

Bmc Cancer

Evaluating Ultrasound as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis

by Qing Feng Shi, Peng Fei Hu, Yong Hong Liu
January 13, 2026

Related Content

Frontiers In Oncology

Case Report: Pembrolizumab unmasks a capillary leak syndrome with chylothorax in early TNBC

Frontiers In Oncology

Comparison of the diagnostic power of serum circulating miR-21, VEGF, and CA15-3 in breast cancer

by Hang Li, Qian Li, Xiaojing Tie, Feng Ji, LiNa Ma, Chunyan Ma
May 28, 2026

Baptist Health South Florida

New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

by
May 26, 2026
5 min